BioCentury | May 6, 2020
Emerging Company Profile

Ventus: A structural edge in innate immunity targets

...SIX:NOVN). Other companies in the target space include NodThera Ltd., which is targeting NLRP3, and Quench Bio...
BioCentury | Jan 28, 2020
Company News

Quenching the flames of inflammatory cell death

...Emerging from stealth Monday with a $50 million A round, Quench Bio is targeting the nexus of...
...new investor AbbVie Ventures. Atlas Venture and Arix Bioscience plc (LSE:ARIX), which co-founded and seeded Quench Bio...
...domain containing 4; NLRP3 (NALP3; CIAS1) - NLR family pyrin domain containing 3 COMPANY PROFILE Quench Bio...
BioCentury | Oct 30, 2018
Company News

Management tracks: Blueprint, Clovis

...Richon is president and CEO of Ribon Therapeutics Inc. (Lexington, Mass.); Truex is CEO of Quench Bio...
BioCentury | Aug 28, 2018
Preclinical News

Stealth start-up Quench among teams tying protein to inflammatory cell death

...Atlas Venture-backed start-up Quench Bio has partnered with a Max Planck Institute for Infection Biology team to...
Items per page:
1 - 4 of 4
BioCentury | May 6, 2020
Emerging Company Profile

Ventus: A structural edge in innate immunity targets

...SIX:NOVN). Other companies in the target space include NodThera Ltd., which is targeting NLRP3, and Quench Bio...
BioCentury | Jan 28, 2020
Company News

Quenching the flames of inflammatory cell death

...Emerging from stealth Monday with a $50 million A round, Quench Bio is targeting the nexus of...
...new investor AbbVie Ventures. Atlas Venture and Arix Bioscience plc (LSE:ARIX), which co-founded and seeded Quench Bio...
...domain containing 4; NLRP3 (NALP3; CIAS1) - NLR family pyrin domain containing 3 COMPANY PROFILE Quench Bio...
BioCentury | Oct 30, 2018
Company News

Management tracks: Blueprint, Clovis

...Richon is president and CEO of Ribon Therapeutics Inc. (Lexington, Mass.); Truex is CEO of Quench Bio...
BioCentury | Aug 28, 2018
Preclinical News

Stealth start-up Quench among teams tying protein to inflammatory cell death

...Atlas Venture-backed start-up Quench Bio has partnered with a Max Planck Institute for Infection Biology team to...
Items per page:
1 - 4 of 4